8-K: American Shared Hospital Services Completes Acquisition of Rhode Island Cancer Centers, Doubles Backlog

American Shared Hospital Services has finalized the acquisition of a 60% stake in three Rhode Island cancer centers, significantly increasing its revenue backlog and expanding its U.S. footprint.

Summary

• American Shared Hospital Services (ASHS) has acquired a 60% majority interest in Southern New England Regional Cancer Center, LLC and Roger Williams Radiation Therapy, LLC, along with certain payor contracts.
• The purchase price for the transaction was $2.85 million, with a previous $285,000 deposit applied to the total.
• An additional $175,000 was paid for a Discovery RT OPEN OC Mid CTM on May 14, 2024.
• The acquisition is expected to add $9 to $10 million in annual revenue and contribute positively to net income.
• ASHS's projected revenue backlog has more than doubled to over $210 million as a result of this acquisition.
• The acquired facilities are located in Woonsocket, Warwick, and Providence, Rhode Island, and are equipped with advanced cancer treatment technology.
• The facilities are located on or adjacent to Care New England and Roger Williams Medical Center, the second and third largest health systems in Rhode Island.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the successful acquisition, significant increase in revenue backlog, and the expected positive impact on net income. The management's comments and the doctor's statement further reinforce the positive outlook.

Positives

• The acquisition expands ASHS's footprint into the U.S. with owned and operated radiation oncology centers.
• The transaction is expected to be accretive to the company's base revenue.
• The acquisition preserves radiation therapy services in strategically convenient locations.
• The company has established strong local relationships with major healthcare systems in Rhode Island.
• The acquired centers are expected to generate revenues for at least the next ten years.

Negatives

• The acquisition was part of the Seller's Chapter 11 bankruptcy process.
• The closing of the transaction was subject to certain conditions, including bankruptcy court approval and approval from the Rhode Island Department of Health.

Risks

• The company faces risks related to economic and market conditions.
• There are risks of variability in financial results between quarters.
• The company is exposed to risks associated with the Gamma Knife and proton therapy businesses.
• Changes to CMS reimbursement rates or methodology could impact the company.
• The timing, financing, and operations of the company's various businesses carry risks.
• There are risks associated with expanding into new markets and integrating acquired businesses.
• Current and future acquisitions may negatively affect the company's financial position.

Future Outlook

The company anticipates the acquired centers will generate revenues for at least the next ten years and plans to continue to build momentum and execute on its growth strategy.

Management Comments

• Ray Stachowiak, Executive Chairman of ASHS, stated that the acquisition is a strong milestone for the company and expands its footprint of owned and operated radiation oncology centers into the U.S.
• Ray Stachowiak also noted that the acquisition adds new revenue streams and is an excellent use of capital.
• David E. Wazer, MD, commented that ASHS's action averted a potential healthcare emergency in Rhode Island by preventing the closure of several treatment facilities.

Industry Context

This acquisition demonstrates ASHS's strategic expansion in the radiation therapy sector, particularly in the U.S. market, and highlights the company's role in providing critical healthcare services amidst industry challenges such as the GenesisCare bankruptcy.

Comparison to Industry Standards

• The acquisition of three radiation therapy centers is a significant move for ASHS, placing it in direct competition with other major players in the radiation oncology market.
• Companies like Varian Medical Systems and Elekta are major competitors in the equipment and technology space, while larger hospital networks and cancer center groups also compete for patient volume.
• The $9-$10 million in annual revenue expected from the acquisition is a substantial increase for ASHS, but it is important to compare this to the overall revenue of competitors to assess its impact.
• The doubling of the backlog to $210 million is a positive indicator of future revenue, but it needs to be compared to the backlog of other companies in the sector to understand its relative strength.
• The acquisition of facilities from a bankruptcy estate is not uncommon in the healthcare sector, but the success of the integration and operation of these facilities will be key to ASHS's long-term performance.

Stakeholder Impact

• Shareholders will benefit from the increased revenue and backlog, potentially leading to higher stock value.
• Employees of the acquired facilities will have continued employment and access to resources.
• Patients will continue to have access to high-quality radiation therapy services in their communities.
• The company's relationships with Care New England and Roger Williams Medical Center will be strengthened.

Next Steps

• The company plans to file the full text of the Fourth Amendment to the Investment Agreement as an exhibit to its Quarterly Report on Form 10-Q for the fiscal quarter ending March 31, 2024.
• The company will also file financial statements and pro forma financial information related to the acquisition in an amendment to the Current Report or together with another report filed with the SEC.
• The company will continue to grow relationships with its JV partners and explore future additional possibilities.

Key Dates

Keywords

Radiation Therapy, Cancer Centers, Acquisition, Revenue Backlog, Healthcare, Linear Accelerators, LINACs, American Shared Hospital Services, ASHS, GenesisCare, Rhode Island